(19)
(11) EP 4 240 397 A1

(12)

(43) Date of publication:
13.09.2023 Bulletin 2023/37

(21) Application number: 21836263.0

(22) Date of filing: 05.11.2021
(51) International Patent Classification (IPC): 
A61K 38/17(2006.01)
C07K 14/725(2006.01)
C07K 16/28(2006.01)
A61P 35/02(2006.01)
C07K 14/705(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/02; C07K 14/7051; C07K 14/7056; C07K 14/70517; C07K 14/70521; C07K 14/70532; C07K 14/70578; C07K 14/70575; C07K 16/2803; C07K 2319/03; C07K 2319/33; C07K 2317/31; A61K 2039/5156; C07K 2317/21; C07K 2317/622; C07K 2317/92; C07K 2317/73; A61K 2039/5158; A61K 39/001112; A61K 39/001113; A61K 2039/804
(86) International application number:
PCT/US2021/058277
(87) International publication number:
WO 2022/099026 (12.05.2022 Gazette 2022/19)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 05.11.2020 US 202017090797

(71) Applicant: Lentigen Technology, Inc.
Gaithersburg, MD 20878 (US)

(72) Inventors:
  • SCHNEIDER, Dina
    Potomac, Maryland 20854 (US)
  • ORENTAS, Rimas J.
    Seattle, Washington 98115 (US)
  • DROPULIC, Boro
    Ellicott City, Maryland 21042 (US)
  • HU, Peirong
    Ijamsville, Maryland 21754 (US)

(74) Representative: Fish & Richardson P.C. 
Highlight Business Towers Mies-van-der-Rohe-Straße 8
80807 München
80807 München (DE)

   


(54) COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD19/CD22 IMMUNOTHERAPY